Enhanced Recovery After Surgery (ERAS) for Laparoscopic Hysterectomy at Low Risk Endometrial Cancer: A Randomized Controlled Trial
Overview
- Phase
- Phase 3
- Intervention
- Not specified
- Conditions
- Endometrial Cancer
- Sponsor
- Fundacion para la Formacion e Investigacion Sanitarias de la Region de Murcia
- Enrollment
- 68
- Locations
- 1
- Primary Endpoint
- Lengh of stay
- Status
- Completed
- Last Updated
- last year
Overview
Brief Summary
Enhanced recovery after surgery (ERAS) programs are designed to achieve early recovery after surgery and a shorter length of stay (LOS) at hospital.
So far there are only three prospective, randomised studies that exclusively analyze patients affected by oncogynecological pathology providing a high level of scientific evidence. To our knowledge, no studies have been conducted specifically on ERAS pathways in endometrial cancer treated by laparoscopy. This study aims to evaluate whether ERAS pathways are beneficial for patients with endometrial cancer, particularly among low-risk early endometrial cancer operated by laparoscopy. Length of stay (LOS), perioperative morbidity and mortality, and perioperative quality of life were analyzed comparing both ERAS and Conventional protocols groups.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Patients undergoing laparoscopic hysterectomy for stage 1A and 1B endometrial cancer
Exclusion Criteria
- •Age under 18 years
- •Liver cirrhosis
- •Psychiatric illness
- •Urgent surgery
- •The patient's desire not to participate.
Outcomes
Primary Outcomes
Lengh of stay
Time Frame: 30 days after surgery
Days of hospitalitation
Day of discharge
Time Frame: 30 days after surgery
Readmisión
Time Frame: During 1st month after surgery
yes/no